‘In Discussion With’

• 

  'In Discussion With'

  Comorbidities and RA – study methodology

  Written by Christine Clark | 9 Jan 2021

  Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases… read more.

• 

  'In Discussion With'

  Implications of findings in comorbidities of RA

  Written by Christine Clark | 8 Jan 2021

  Interview and article by Chrstine Clark The findings of a recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) could have important implications… read more.

• 

  'In Discussion With'

  Comorbidities and RA – study findings

  Written by Christine Clark | 7 Jan 2021

  Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr… read more.

• 

  'In Discussion With'

  Investigating comorbidities and rheumatoid arthritis

  Written by Christine Clark | 6 Jan 2021

  Interview and article by Christine Clark. Rheumatoid arthritis (RA) affects about one percent of the population in the UK and comorbidities are reported to be common. A recent… read more.

• 

  Colin Brown

  Dear Santa, please bring indomethacin and ivermectin

  Written by Christine Clark | 21 Dec 2020

  Article written by Christine Clark and Colin Brown We are hearing almost hourly warnings of how the NHS will soon be overwhelmed with Covid-19 cases. Yet we have… read more.

• 

  'In Discussion With'

  Vaccines – getting the message across

  Written by Gary Finnegan | 28 Nov 2020

  Interview and article by Christine Clark Knowing that your GP or pharmacist has had the vaccine can be deeply reassuring, according to Gary Finnegan, health journalist and Editor… read more.

• 

  'In Discussion With'

  Vaccine confidence and hesitancy

  Written by Gary Finnegan | 27 Nov 2020

  Interview and article by Christine Clark Understanding the three Cs of vaccine hesitancy could be the key to ensuring effective uptake of covid-19 vaccines, according to Gary Finnegan,… read more.

• 

  'In Discussion With'

  Vaccines: where are we now?

  Written by Gary Finnegan | 26 Nov 2020

  Interview and article by Christine Clark As planning for a mass covid vaccination campaign gets started, an understanding of vaccines and the factors that drive vaccine confidence will… read more.

• 

  'In Discussion With'

  Pandemic critical care drug requirements – lessons learned

  Written by Christine Clark | 18 Nov 2020

  Interview and article by Christine Clark Pharmacist Anita Hogg explains how well Medicines Optimisation Innovation Centre (MOIC) model to estimate the critical care drug requirements during the covid-19… read more.

• 

  'In Discussion With'

  Estimating pandemic critical care drug requirements

  Written by Christine Clark | 17 Nov 2020

  Interview and article by Christine Clark Pharmacist Anita Hogg explains how the Medicines Optimisation Innovation Centre (MOIC) in Belfast developed and applied a model to estimate the critical… read more.

• 

  'In Discussion With'

  The MOIC and pandemic critical care drug requirements

  Written by Christine Clark | 16 Nov 2020

  Interview and article by Christine Clark Pharmacist Anita Hogg explains the work of the Medicines Optimisation Innovation Centre (MOIC) in Belfast and how the Centre helped to ensure… read more.

• 

  'In Discussion With'

  Practice pharmacy services during the covid pandemic and in the future

  Written by Christine Clark | 4 Nov 2020

  Interview and article by Christine Clark Practice pharmacists were able to adjust and simplify drug treatment to ensure continued effective treatment during the covid pandemic – and could… read more.